Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome

Mira T Tanenbaum, BA, Anna Shvygina, BS, Vaishnavi Sridhar, BS, Jennifer E. Vaughn, MD MSPH, Mark Joseph, MD

Blood (2019) 134 (Supplement_1): 4854.

https://doi.org/10.1182/blood-2019-131561

Published: 2019

Journal Articles

Leukocytosis, but Not Thrombocytosis, May Constitute a Prothrombotic Pathway in Women with Ovarian Cancer: A Cohort Study

Javier Lopez Salazar, Laura A Ramirez Tirado, MD, Nora Gomez Contreras, MD, Oscar Arrieta, MD PhD, Dolores Gallardo, MD, Gabriela Cesarman-Maus, MD PhD

Blood (2018) 132 (Supplement 1): 1228.

https://doi.org/10.1182/blood-2018-99-120193

Published: 2018

Journal Articles

CML In Pregnancy: A Case Report Using Leukapheresis and Literature Review

Yellu Mehander, M.D., Stephen Medlin, DO, FACP

Blood (2013) 122 (21): 5177.

https://doi.org/10.1182/blood.V122.21.5177.5177

Published: 2013

Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia

Anjali Advani, MD, Paul Elson, Eric D. Hsi, MD, Randall Davis, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward Copelan, MD, Hien K. Duong, MD, Bethany Foster, Mary Lynn Rush, Leslie Farhat, Mikkael A. Sekeres, MD, MS

Blood (2012) 120 (21): 3595.

https://doi.org/10.1182/blood.V120.21.3595.3595

Published: 2012

Journal Articles

An Approach to the “Untransfusable” Patient

Gemma Louise Crighton, MD, Philip A Thompson, MD, Mary Gaskell, Marija Borosak, FRCPA, FRACP, MBBS, Anne C Dykes, MD, FRACP, FRCPA, Jennifer Condon, Scott McArdle, Merrole Faye Cole-Sinclair

Blood (2012) 120 (21): 4385.

https://doi.org/10.1182/blood.V120.21.4385.4385

Published: 2012

Journal Articles

Profile of Steroid Toxicity During Maintenance Treatment in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

Jo Tomlins, RGN, BN, MSc, Samar Kulkarni, MD, MRCP, FRCPath, Clare Rowntree, Nicholas Goulden, FRCPath, Chris Mitchell, MD, PhD, Rachael Hough, FRCPath, Sue Richards, PhD, Rachel Clack, Adrian JC Bloor, PhD, FRCP, FRCPath, Ajay J Vora, FRCPath

Blood (2012) 120 (21): 4305.

https://doi.org/10.1182/blood.V120.21.4305.4305

Published: 2012

Journal Articles

Final Analysis of MELISSE, a Large Multicentric Observational Study to Determine Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Treated with Immunomodulator Drugs

Xavier Leleu, MD, PhD, Laurent Daley, Philippe Rodon, MD, Cyrille Hulin, MD, Charles Dauriac, MD, Hacini Hacini, MD, Olivier Decaux, MD, PhD, Jean-Claude Eisemann, MD, Olivier Fitoussi, MD, Laurent Voillat, MD, Borhane Slama, MD, Ahmad Al Jijakli, MD, Carinne Chaleteix, MD, Régis Costello, MD, Anne Lamblin, Patrick Natta, MD, Jean Paul Fermand, MD, Philippe Moreau, MD

Blood (2011) 118 (21): 1235.

https://doi.org/10.1182/blood.V118.21.1235.1235

Published: 2011

Journal Articles

Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study

Grigoris T Gerotziafas, Miltos Chrysanthidis, Reda Isaad, Hela Baccouche, Chrysoula Papageorgiou, Brigitte Thiolier, Alex C Spyropoulos, MD, Vassiliki Galea, Asterios Katsamouris, Dimitris Kiskinis, Ismail Elalamy

Blood (2010) 116 (21): 3337.

https://doi.org/10.1182/blood.V116.21.3337.3337

Published: 2010

Journal Articles

Venous Thromboembolism in the Elderly: Epidemiological Data Overview Based On the 2149-Patients Prospective OPTIMEV Cohort.

Gilles Pernod, Jose Labarere, Marie Antoinette Sevestre, Jean Luc Bosson

Blood (2009) 114 (22): 5063.

https://doi.org/10.1182/blood.V114.22.5063.5063

Published: 2009

Journal Articles

Clinical Predictors of Prophylaxis Use Prior to the Onset of Acute Venous Thromboembolism in Hospitalized Patients: Swiss Venous ThromboEmbolism Registry (SWIVTER)

Nils Kucher, MD, David Spirk, MD, Christoph Kalka, MD, Lucia Mazzolai, MD, Daniel Nobel, MD, Martin Banyai, MD, Beat Frauchiger, MD, Henri Bounameaux, MD

Blood (2008) 112 (11): 3019.

https://doi.org/10.1182/blood.V112.11.3019.3019

Published: 2008

Journal Articles

Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature

Alfonso Iorio, Esmeralda Filippucci, Maura Marcucci, Clive Kearon, MB, PhD, Gualtiero Palareti

Blood (2008) 112 (11): 3029.

https://doi.org/10.1182/blood.V112.11.3029.3029

Published: 2008

Journal Articles

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

Roger D Yusen, Russell D Hull, Sebastian M Schellong, Victor F Tapson, Manuel Monreal, Michel Meyer Samama, Min Chen, Alexander GG Turpie

Blood (2008) 112 (11): 438.

https://doi.org/10.1182/blood.V112.11.438.438

Published: 2008

Journal Articles

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

Frederick A Anderson, Jr., PhD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Bruno Deslandes, Victor F Tapson, MD, Meyer Michel Samama, MD, PharmD, Alexander GG Turpie, MD, Roger D Yusen, MD, MPH, Herve Decousus, MD, Alexander T Cohen, MBBS, MSc, MD, FRACP, Manuel Monreal, MD

Blood (2008) 112 (11): 1981.

https://doi.org/10.1182/blood.V112.11.1981.1981

Published: 2008

Journal Articles

Risk Factors for Isolated Pulmonary Embolism Are Opposite to Those for DVT-Associated PE: Results of the 7532-Patients Prospective OPTIMEV Cohort Study.

Jean Luc Bosson, MD, PhD, Marie Antoinette Sevestre, MD, Jose Labarere, MD, PhD, Joel Constans, MD, Isabelle Quere, MD, Gilles Pernod, MD, PhD

Blood (2007) 110 (11): 3977.

https://doi.org/10.1182/blood.V110.11.3977.3977

Published: 2007

Journal Articles

Management and Strategy of Thromboprophylaxis for Venous Thromboembolism in Pregnancy.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2007) 110 (11): 3996.

https://doi.org/10.1182/blood.V110.11.3996.3996

Published: 2007

Journal Articles

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Roger D. Yusen, Russell D. Hull, Sebastian M. Schellong, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie

Blood (2007) 110 (11): 1862.

https://doi.org/10.1182/blood.V110.11.1862.1862

Published: 2007

Journal Articles

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Victor F. Tapson, Russell D. Hull, Sebastian M. Schellong, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1863.

https://doi.org/10.1182/blood.V110.11.1863.1863

Published: 2007

Journal Articles

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Sebastian M. Schellong, Russell D. Hull, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1870.

https://doi.org/10.1182/blood.V110.11.1870.1870

Published: 2007

Journal Articles

Derivation and Validation of a Prediction Tool for Venous Thromboembolism: A VERITY Registry Study.

Roopen Arya, MB, PhD, Shankaranarayana Paneesha, MD, Aidan McManus, PhD, Nick Parsons, PhD, Nicholas Scriven, MBBS, Tim Farren, BSc, Tim Nokes, MD, Denise O’Shaughnessy, MD, PhD, Peter Rose, MD

Blood (2007) 110 (11): 697.

https://doi.org/10.1182/blood.V110.11.697.697

Published: 2007

Journal Articles

Operationalizing the Concept of “Immobility” for Better Targeting of Thromboprophylaxis in Medical Patients: How the Literature Falls Short.

Laura Desrosiers, NMSc(A), Susan R. Kahn, MD FRPCP MSc, Jessica Emed, N MSc(A)

Blood (2007) 110 (11): 968.

https://doi.org/10.1182/blood.V110.11.968.968

Published: 2007

NARROW

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome

Leukocytosis, but Not Thrombocytosis, May Constitute a Prothrombotic Pathway in Women with Ovarian Cancer: A Cohort Study

CML In Pregnancy: A Case Report Using Leukapheresis and Literature Review

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia

An Approach to the “Untransfusable” Patient

Profile of Steroid Toxicity During Maintenance Treatment in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

Final Analysis of MELISSE, a Large Multicentric Observational Study to Determine Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Treated with Immunomodulator Drugs

Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study

Venous Thromboembolism in the Elderly: Epidemiological Data Overview Based On the 2149-Patients Prospective OPTIMEV Cohort.

Clinical Predictors of Prophylaxis Use Prior to the Onset of Acute Venous Thromboembolism in Hospitalized Patients: Swiss Venous ThromboEmbolism Registry (SWIVTER)

Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

Risk Factors for Isolated Pulmonary Embolism Are Opposite to Those for DVT-Associated PE: Results of the 7532-Patients Prospective OPTIMEV Cohort Study.

Management and Strategy of Thromboprophylaxis for Venous Thromboembolism in Pregnancy.

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Derivation and Validation of a Prediction Tool for Venous Thromboembolism: A VERITY Registry Study.

Operationalizing the Concept of “Immobility” for Better Targeting of Thromboprophylaxis in Medical Patients: How the Literature Falls Short.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only